Braille Code for Chemical Notation, 1997: Print
by American Printing House for the Blind
Last verified June 15, 2026 · classified May 14, 2026
What it is
Summary
AI-generated from vendor-published content · May 14, 2026
This is the print edition of the 1997 Braille Authority of North America (BANA) codebook for representing chemical notation in braille — covering how elements, formulas, equations, and chemical symbols are transcribed into tactile format. It's a reference manual for braille transcribers, teachers of students with visual impairments (TVIs), and AT professionals who produce or review scientific materials for blind students. The book itself is not a braille document; it's the print guide explaining the rules and standards that govern how chemistry content gets converted. Note that this product is discontinued, so availability will depend on finding existing stock or library copies — the underlying standard has also since been superseded by updates to the Nemeth Code and BANA chemistry guidance.
Quick Facts Catalog facts · auto-generated
- AT Act lending
- Out of pocket
- School district
What Setup Looks Like
- Out of the box
Use as a reference guide for transcribing or reviewing chemical notation in braille — no setup required.
Getting it
Try Before You Buy
Devices like this are often available to borrow through your state's AT Act program — typically free or low-cost — so you can try it before buying or pursuing funding.
Where to Get It
Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →
Wondering how equipment like this gets paid for? See the official funding programs in your state.
Compare & explore
Sources & fine print
Vendor facts (name, price, platforms, vendor link) sourced from American Printing House for the Blind — view on vendor site; last verified June 15, 2026.
Classification & description AI-generated from vendor-published content on May 14, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.